Podcasts about leavitt partners

In the second episode of our special series on recommendations to the Trump administration, Quality Matters host Andy Reynolds welcomes Ryan Howells, Principal at Leavitt Partners, for an illuminating discussion on transforming digital quality and data exchange..Ryan shares fresh ideas from the Leavitt Partners roadmap to reshape digital health infrastructure by embracing scalable, internet-based standards and dismantling policy barriers. At the core of this conversation is that effective data exchange must be powered not only by modern standards, but by trust among people and institutions. Ryan's suggestions include:·   Implementing APIs at scale to reduce manual processes and administrative waste. The same APIs that power everyday apps can streamline data exchange between payers and providers, replacing faxes, phone calls and redundant forms.·   Certifying data exchange—not just software functionality. Instead of dictating how systems are built, federal policy should focus on certifying APIs, allowing EHR vendors the flexibility to innovate while helping ensure that data flows freely.·   Establishing “tables of trust.” Regional collaboration among payers, providers and government agencies can test new digital infrastructure in real-world settings and be the model for national expansion.Digital quality transformation will require more than just tech upgrades—we must rethink relationships, trust and policy levers. Listen to this episode to learn how the Trump administration could support a data-driven revolution in health care quality.Key Quote:“I've been doing this for a long time, almost 30 years. But when I go into my doctor's office and I still have to fill out a clipboard with a piece of paper on it with information I know they already have, it is painful. The best representation of whether we are making progress is, I don't want to ever go into a doctor's office and fill out a clipboard. If I could just not fill out my health history, my demographic information, whether information should be sent to my doctor—if all that is just in the doctor's system—I would say we have made progress. Because at that point it will be real to the individual. Think about it in terms of digitizing all of the health care data and making sure it is with the right person, at the right time, in the right place to make the right decisions. When that happens, we'll know we've made significant progress.” Ryan Howells Time Stamps:(02:27) Why Implementing Health Care APIs is Hard(05:32) Tables of Trust: A Case Study from Utah(07:03) Scaling Trust and Interoperability(13:12) Eliminating Manual Processes (18:23) Solving Diverse Use Cases (19:36) Encouraging Early Adoption of APIsLinks:NCQA Recommendations to the Trump Administration Leavitt Partners Recommendations: “Kill the Clipboard!”Connect with Ryan Howells

Send us a textDr. James L. Madara, MD, is CEO and Executive Vice President of the American Medical Association ( https://www.ama-assn.org/about/authors-news-leadership-viewpoints/james-l-madara-md ), the United States' largest physician organization. He also holds the academic title of adjunct professor of pathology at Northwestern University ( https://www.pathology.northwestern.edu/Faculty/profile.html?xid=24099 ).Since taking the reins of the AMA in 2011, Dr. Madara has helped sculpt the organization's visionary long-term strategic plan. He also serves as Chairman of Health2047 Inc. ( https://health2047.com/ ), the wholly-owned innovation subsidiary of the AMA, created to overcome systemic dysfunction in U.S. health care and located in Silicon Valley. Working closely with the AMA, Health2047 finds, forms and scales transformative health care spinout companies in four fields: chronic care, data utility, radical productivity and health care value. Several companies have been launched to date.Prior to the AMA, Dr. Madara spent the first 22 years of his career at Harvard Medical School, receiving both clinical and research training, serving as a tenured professor, and as director of the NIH-sponsored Harvard Digestive Diseases Center. Following five years as chair of pathology and laboratory medicine at Emory University, Dr. Madara served as dean of both biology and medicine, and then as CEO of the University of Chicago Medical Center, bringing together the university's biomedical research, teaching and clinical activities. While there he oversaw the renewal of the institution's biomedical campus and engineered significant new affiliations with community hospitals, teaching hospital systems, community clinics and national research organizations.Dr. Madara also served as senior advisor with Leavitt Partners, an innovative health care consulting and private-equity firm founded by former Health and Human Services Secretary Mike Leavitt.Having published more than 200 original papers and chapters, Dr. Madara has served as editor-in-chief of the American Journal of Pathology and as president of the American Board of Pathology.In addition to Modern Healthcare consistently naming him as one of the nation's 50 most influential physician executives, as well as one of the nation's 100 most influential people in health care, Dr. Madara has been recognized with several national and international awards. These include the prestigious MERIT Award from the National Institutes of Health, the Davenport Award for lifetime achievement in gastrointestinal disease from the American Physiological Society, and the Mentoring Award for lifetime achievement from the American Gastroenterological Society.Dr. Madara is an elected member of both the American Society of Clinical Investigation and the Association of American Physicians. He also co-chairs the Value Incentives & Systems Action Collaborative of the National Academy of Medicine (NAM), and is a member of NAM's Leadership Consortium for Value & Science-Driven Health Care.#JamesMadara #AmericanMedicalAssociation #AMA #Physicians #Pathology #IntestinalEpithelialPathobiology #MedicalSchool #MedicalEducation #HealthEquity #UniversityOfChicago #SocialDeterminantsOfHealth  #NorthwesternUniversity #Health2047 #VentureCapital #ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #ViralPodcast #STEM #Innovation #Technology #Science #ResearchSupport the show

Bill Steiger, former USAID Chief of Staff: Partnerships and Innovation at USAID, joins Mike Shanley to discuss USAID's role in foreign policy, innovation at USAID, partnerships and localization, and USAID funding and direction.  Biography: Bill Steiger is a Global Health Consultant at the George W. Bush Institute. Previously, he was Managing Director of Pink Ribbon Red Ribbon, focusing on combating breast and cervical cancer in sub-Saharan Africa and Latin America. He led strategic planning for the initiative's expansion. In 2012, Steiger served as a Senior Advisor at the Global Fund to Fight AIDS, Tuberculosis, and Malaria, where he helped restructure the Secretariat and design a new funding model. He also directed a panel reviewing the Global Fund's operations, leading to significant reforms. Steiger has worked with Leavitt Partners on international health projects and held key roles at the U.S. Department of Health and Human Services from 2001 to 2009. There, he advised on global health issues and represented the U.S. in various international organizations. He has served on the boards of major health organizations like the World Health Organization and the Global Fund. Steiger holds a Ph.D. in Latin American History from UCLA and a bachelor's degree from Yale. LEARN MORE Thank you for tuning into this episode of the Aid Market Podcast. You can learn more about working with USAID by visiting our homepage: Konektid International and AidKonekt. To connect with our team directly, message the host Mike Shanley on LinkedIn.

Ryan Howells is a leading expert in digital health policy and interoperability from Leavitt Partners, an HMA company. Ryan has been a catalyst for change since the early days of the internet to his current role in advancing consumer-directed health data exchange through application programming interfaces (API). In this episode, he discusses the evolution of digital health, the challenges of data accessibility, and the transformative potential of AI in healthcare. Whether you're a healthcare professional or simply interested in healthcare innovation, this podcast offers practical solutions and visionary insights that can help reimagine the way we deliver and experience healthcare.

In this edition of Pophealth Week, we welcome David Muhlestein, PhD, JD, an influential figure in healthcare research and entrepreneurship with a passion for reforming healthcare payment and delivery systems. Our conversation centers on the advancement and, potentially, the maturation of the market towards value-based care models, spanning from HMOs to ACOs and including a variety of initiatives in both public (Medicare, Medicaid) and private sectors. David offers his expertise to define the landscape, shedding light on the hurdles and prospects facing practitioners in this evolving space. A proclaimed data and policy enthusiast, David is renowned for his contributions to discussions on value-based care and the progression of healthcare systems. His roles include Visiting Policy Fellow at the Margolis Center for Health Policy at Duke University and Adjunct Assistant Professor at The Ohio State University College of Public Health. His previous positions have seen him as the Chief Research and Innovation Officer for Health Management Associates, and Chief Strategy and Chief Research Officer for Leavitt Partners, along with a tenure as Adjunct Assistant Professor of The Dartmouth Institute (TDI) at Dartmouth College. David's academic credentials are comprehensive, holding a PhD in Health Services Management and Policy, JD, MHA, and MS from The Ohio State University, alongside a BA from Brigham Young University. Dive into a thought-provoking discussion on the future of healthcare with us!

From airports to the world of healthcare, digital identities have seamlessly transformed how we navigate and personalize our experiences. In this episode, Saul Marquez hosts Jason Sherwin, Senior Director of Business Development at Clear, and Ryan Howells, a Principal at Leavitt Partners and Program Manager at CARIN Alliance. The discussion delves into the significance of digital identity in healthcare. Jason explains how Clear's consumer-facing identity platform, known for its privacy and trust in the aviation industry, can empower safer and more convenient healthcare experiences. Ryan, representing the CARIN Alliance, highlights the importance of identity and patient data access, emphasizing their work in enabling consumers to control their health information. They both describe practical initiatives where consumers can access their health data easily, offering providers and payers the means to streamline processes and enhance patient experiences. Learn how digital identity solutions can revolutionize healthcare and make patient data more accessible and user-friendly. Resources: Connect with and follow Jason on LinkedIn. Visit CLEAR on their website and follow them on LinkedIn. Connect with and follow Ryan on LinkedIn. Learn more about Leavitt Partners on this website and LinkedIn. Visit CARIN Alliance on their website and follow them on LinkedIn.

About Jason Sherwin:Jason Sherwin is the Senior Director of Business Development at Clear. He is a passionate strategic thinker who is driven to challenge long-held healthcare standards. Jason has 13 years of expertise in the health technology field, focusing on product planning and commercial growth. In his role at Clear, Jason works cross-functionally with executives and other leaders in marketing, operations, and IT to maximize outcomes.Jason completed his MBA at the Stern School of Business, which enabled him to apply the principles he learned to his real-world work. His expertise in designing successful strategies for managing organizational change and gauging success was further boosted by his specialization in Leadership & Change Management. Jason also completed his Bachelor of Science at Skidmore College in 2009.About Ryan Howells:Ryan Howells is Principal at Leavitt Partners and Program Manager at CARIN Alliance. He focuses on healthcare policy and interoperability issues, working with key stakeholders, including the White House, Congress, HHS, and VHA. His role is instrumental in driving consumer access to healthcare data and enabling interoperability in the healthcare ecosystem.Ryan is also a Member of the Medicaid Information Technology Architecture (MITA) Governance Board at the Centers for Medicare & Medicaid Services, intending to provide strategic direction and tactic oversight. Ryan has earned his Master of Arts in Health Services Administration at the University of Southern California.Things You'll Learn:In healthcare, identity is critical. Getting the patient's identity wrong isn't an option.Streamlining healthcare through digital identity can significantly reduce provider costs and improve patient matching.The 21st Century Cures Act, Fire APIs, and identity-proof credentials are revolutionizing how consumers access their healthcare data.Individuals can prove their identity, for example, when checking in for an appointment with their doctor, through a unique digital identity, similar to taking a selfie.The goal is to place patients in control of their health information, providing a seamless experience.Trust is a crucial aspect, making the digital identity a reliable solution for healthcare data.Resources:Connect with and follow Jason on LinkedIn.Visit CLEAR on their website and follow them on LinkedIn.Connect with and follow Ryan on LinkedIn.Learn more about Leavitt Partners on this website and LinkedIn.Visit CARIN Alliance on their website and follow them on LinkedIn. 

Host: Taylor Morgan Last week we learned that the Utah Republican Party opted out of the 2024 presidential primary. We also learned about a national Republican resolution to call for single-day voting with ID-protected paper ballots. Rich McKeown, Co-founder of Leavitt Partners and Chairman of the Count My Vote committee, joins host Taylor Morgan to share his reaction to this and how he thinks this will affect voter participation in the primary election.See omnystudio.com/listener for privacy information.

Host: Taylor Morgan Will the Utah GOP's recent decisions affect voter participation? Last week we learned that the Utah Republican Party opted out of the 2024 presidential primary. We also learned about a national Republican resolution to call for single-day voting with ID-protected paper ballots. Rich McKeown, Co-founder of Leavitt Partners and Chairman of the Count My Vote committee, joins host Taylor Morgan to share his reaction to this and how he thinks this will affect voter participation in the primary election. House Freedom Caucus says they will oppose a stopgap funding bill that excludes their policy demands The House Freedom Caucus has announced today that they will not be supporting any stopgap funding bill that doesn't include their policy priorities. What exactly are they asking for, and why? Andy Field, ABC News Correspondent in Washington, joins the show with the latest. Are Utah's political figures “disagreeing better” now? It's been a little over a month since Governor Spencer Cox released the “Disagree Better” initiative… How effective has it been so far? Are Utah's politicians communicating better as a result? Jason Perry, Director of the Hinckley Institute of Politics at the University of Utah, joins the show to discuss the importance of not just communicating with each other, but also taking a moment to listen and understand the other side. Legal scholars argue that former President Trump is ineligible to run for president Even after being indicted multiple times, former President Donald Trump is still in the race to run for president in 2024. Now, legal scholars are arguing that the 14th Amendment disqualifies him from running again. Is this a legitimate argument? KSL Legal Analyst Greg Skordas joins the discussionSee omnystudio.com/listener for privacy information.

Hey, thanks so much to kwebs14 for your super nice review on iTunes the other day. Kwebs wrote: [I have] learned so much, shared so many episodes with colleagues, clients … and gained so much value from regularly listening to [Relentless Health Value]. … Thank you … for providing the platform for so many that believe that we can consistently do better in healthcare. Thanks much for writing this. I think our Relentless Tribe is a unique group, and every day of every week I admire your willingness to hear some things that might be pretty hard to hear because they may hit pretty close to home. Dr. Benjamin Schwartz was talking about the podcast on LinkedIn the other day, and he said he doesn't always agree with guests or the discussion but he always learns something and each episode stimulates and challenges his thoughts and opinions. Yes … to all of this. This is our goal in a nutshell: to help those who want to do better in healthcare to have the insight, the information, the other side of the story, the differing opinion, whatever you need to conceive of the action that you want to take. So, thank you so much to everybody who listens. You are the ones who are going to make a difference, and I thank you from the bottom of my heart for doing what you do every day for patients and communities. Alright, so in this healthcare podcast, we are going to answer an FAQ—a listener question I have gotten a lot lately in various forms. Let me common denominator the inquiry: What does it mean to be clinically integrated, and how does a provider organization/practice/CIN (clinically integrated network) know if they are actually clinically integrated or not? Also, the corollary to this question, which is how do CINs—or anybody, really—know if they are clinically integrated enough to start thinking about taking on downside risk? I asked David Muhlestein this question, and then we talk about his answer for 25 minutes. So, like most things in healthcare, it is filled with nuance; but if I was going to oversimplify his answer in one sentence, it's this: Did the practice change how they are practicing medicine in order to drive predetermined outcomes? This is the litmus test for whether care is integrated. Did practice patterns change within participating entities from whatever they were before to a new way of working? Did the team(s) reorient with a goal to attain some documented patient outcomes, be those outcomes patient satisfaction and/or clinical endpoints and/or functional endpoints? If no sort of fundamental change happened, probably it's a no on the clinical integration question. Another litmus test question I've also heard is this: Is the practice looking to get paid more for successes they've already had in upside risk arrangements with kind of little or no desire to transform the practice into a new practice model? If yes, then again, it's gonna be a no on the clinical integration question. The thing is with all of this … well, let me quote Dr. John Lee, who said this pretty succinctly on LinkedIn recently. He said, “Downside risk fundamentally changes how you have to think as a physician and how you manage your patient cohort. You start thinking about team-based care and using analytics.” Yes … interesting. The point Dr. Lee is making — which is kind of inferred, actually, in the listener questions, so let me just state the obvious, which is so obvious it could easily be overlooked — if you are able to take on downside risk and succeed, you're probably clinically integrated. If you're not, you probably aren't. Said another way (this might get a little chicken and egg-y), do you clinically integrate so that you can get the kind of risk-based contracts that enabled Iora, for example, to represent 5% of One Medical's patient base and 50% of its revenue? I have heard similar profitability stories about ChenMed and Oak Street. They all have capitated downside risk accountable care contracts. And have you seen what some of their leadership teams are minting? Obviously, the capitated downside risk when you're integrated gig can be highly profitable. But ... seems like also the community and outcomes are kind of great. Are they doing well by doing good? I'll grant you I might be convinced based on what I've seen. Galileo is another one. Cityblock. But the fundamental question is, do you integrate first and then go after the contracts? Or is it best to wait until there's a decent accountable opportunity on offer and then, sufficiently incented, change the practice? I do not know. I do know, however, what Scott Conard, MD, said in episode 391. I will poorly paraphrase. He said that if better patient outcomes are desired, there must be clinical integration and practice pattern changes. He said his practice went ahead and instituted these changes to improve patient care and did so within a pretty full-on FFS (fee-for-service) environment. My conclusion with all of this? It takes strong leadership with team-building skills and a strong family/community-centric mission to pull off a successful foray into accountable care with downside risk. These same talented and mission-driven leaders probably could manage to improve patient care and lower costs in an FFS environment as well. The converse of this is also likely true: Weak and ineffectual leaders can make a quadruple nothing burger mess in even the best VBC (value-based care) model. Yes … lots to unpack there. I am interested in your thoughts. In this episode, as mentioned, I am speaking with David Muhlestein, who is the chief research and innovation officer with Health Management Associates, or HMA. He has spent the past decade-plus studying ACOs (accountable care organizations) and value-based care, trying to understand what works, what doesn't, and how you change the business models to be successful under these new models of payment. Here is a short version of David's advice to clinically integrate and be ready for downside risk: ·       Step 1: Understand where you are—this includes doing a very clear-eyed self-assessment. ·       Step 2: Assess the needs of your patient population and focus on things where your capacity meets the needs of the population that you serve in the most impactful way. ·       Step 3: Take the outcome of step 2—which is basically whatcha gonna do to fix the most consequential problems that your patients have—and identify the processes by which you will do this. ·       Step 4: Do not boil the ocean. Start with a subset of patients and figure out the exact plan to do better to manage that population—easier said than done, of course. (Betsy Seals, by the way said something along these exact same lines in the shows giving advice to Medicare Advantage plans. And Karen Root [EP381] also alludes to something similar as she talks about how to socialize innovation. So clearly, this advice can be universalized.) You can learn more by emailing David at dmuhlestein@healthmanagement.com and by connecting with him on LinkedIn.     David Muhlestein, PhD, JD, is chief research and innovation officer for Health Management Associates (HMA). He is responsible for the firm's self-directed research and supports strategic planning and innovation. David's research and expertise center on healthcare payment and delivery transformation, understanding healthcare markets, and evaluating how the broader healthcare system is changing. He is a self-identified data nerd and regularly speaks and writes about healthcare system evolution. David joined HMA via its acquisition of Leavitt Partners in 2021, where he was the chief strategy and chief research officer. Additionally, David is a visiting policy fellow at the Margolis Center for Health Policy at Duke University, adjunct assistant professor at The Ohio State University College of Public Health, and a visiting fellow at the Accountable Care Learning Collaborative. He previously served as adjunct assistant professor of The Dartmouth Institute (TDI) at the Geisel School of Medicine at Dartmouth College. David earned his PhD in health services management and policy, JD, MHA, and MS from The Ohio State University and a BA from Brigham Young University.   07:57 What does it mean to be clinically integrated? 10:23 How does changing practice patterns count as becoming clinically integrated? 11:11 How do you change the delivery of care to get better outcomes? 12:05 What does it mean to see better outcomes when becoming clinically integrated? 14:46 EP176 with Dr. Robert Pearl. 17:42 “Their structure is dictating what they are going to prioritize.” 19:02 “How do you care for the patients that have yet to come and see you?” 20:16 EP391 with Scott Conard, MD. 22:38 “When you're integrated, you realize you're not alone.” 25:50 Why does clinically integrating require a significant mindset change? 28:55 What does this country need to do from a policy perspective for this change? 30:24 EP326 with Rishi Wadhera, MD, MPP.   You can learn more by emailing David at dmuhlestein@healthmanagement.com and by connecting with him on LinkedIn.   @DavidMuhlestein of @HMAConsultants discusses #integratedcare on our #healthcarepodcast. #healthcare #podcast #digitalhealth   Recent past interviews: Click a guest's name for their latest RHV episode! Nikhil Krishnan (Encore! EP355), Emily Kagan Trenchard, Dr Scott Conard, Gloria Sachdev and Chris Skisak, Mike Thompson, Dr Rishi Wadhera (Encore! EP326), Ge Bai (Encore! EP356), Dave Dierk and Stacey Richter (INBW37), Merrill Goozner, Betsy Seals (EP387), Stacey Richter (INBW36), Dr Eric Bricker (Encore! EP351), Al Lewis, Dan Mendelson, Wendell Potter, Nick Stefanizzi, Brian Klepper (Encore! EP335), Dr Aaron Mitchell (EP382), Karen Root, Mark Miller, AJ Loiacono, Josh LaRosa, Stacey Richter (INBW35), Rebecca Etz (Encore! EP295), Olivia Webb (Encore! EP337), Mike Baldzicki, Lisa Bari, Betsy Seals (EP375)      

The digital transformation of healthcare has been a long and winding road, but one that is starting to open new possibilities in every aspect of business operations, care delivery and consumer experiences. The critical aspect to all of this is a newfound access to data.Dale Sanders and Ryan Howells have been at the forefront of the movement to unlock data in healthcare and help organization leverage it to actually drive business and clinical performance. As Principal at Leavitt Partners, Ryan works with the White House, Congress, HHS, and VHA on health care policy and interoperability issues. He also currently leads the CARIN Alliance, a multi-sector, public-private alliance focused on giving consumers digital access to their health information. Dale is Chief Strategy officer at Intelligent Medical Objects (IMO) where he closely analyzes market needs and challenges to set IMO's strategic direction developing products that deliver critical data quality improvements and insights to improve patient care.In this episode of Healthcare is Hard, Keith Figlioli draws on the decades of experience Dale and Ryan have driving healthcare data policy and strategy. Their discussion touches on the intricate details of healthcare data, the everyday impacts that data can have on healthcare consumers, and many points in between. They cover topics including:Entering the “app economy” for healthcare. Ryan points out that almost every other aspect of the consumer world entered the app economy almost 20 years ago. But for healthcare, that transition is just starting. They talk about how the emergence of structured data eliminates the need to rely solely on legacy vendors to solve problems, and the potential it unlocks for creating new, billion dollar companies.Encouraging physicians to stage a riot. The group discusses how quality measures are creating administrative overhead, burning-out physicians, and affecting data quality in ways that many people don't realize. With revenue streams that are tied to these outdated processes and make them difficult to change, a shift towards measuring outcomes will not be easy. What will it take? Dale says one option he's encouraging is an uprising among physicians.The B-to-C-to-B data strategy. Data privacy has been a big hurdle to enabling the exchange of EHR data and patient information between organizations. But what if patients have full control of their data and can be the conduit between providers and other organizations? Ryan talks about how this can fundamentally change the issue of data portability by eliminating the need to negotiate and implement complex legal agreements required to exchange data between two organizations. They talk about how this strategy hinges on the ability to verify digital identities.Disrupting EHR incumbents. With so much change on the horizon and data access creating new possibilities for healthcare's core infrastructure, should incumbent EHR vendors be nervous? Dale says a new enterprise infrastructure in healthcare – a next-gen EHR that's focused on team-based care, not the encounter – is imperative. And he offers advice on how to get there. Ryan adds his belief that the industry needs a complete new coding system built for value-based care, not fee for service.To hear Keith, Dale and Ryan talk about these topics and more, listen to this episode of Healthcare is Hard: A Podcast for Insiders.

David W.K. Acheson, M.D., F.R.C.P., is the President and CEO of The Acheson Group, a consulting firm that provides strategic advice on all matters relating to food safety and food defense, as well as recall and crisis management support, to food companies and ancillary technology companies around the world. Prior to founding The Acheson Group in 2013, Dr. Acheson served as the Chief Medical Officer in the U.S. Food and Drug Administration's Center for Food Safety and Applied Nutrition (FDA's CFSAN). Following several other positions at FDA, he was appointed Associate Commissioner for Foods, which gave him an agency-wide leadership role for all food and feed issues, including health promotion and nutrition. Dr. Acheson was also a partner at Leavitt Partners and managed Leavitt Partners Global Food Safety Solutions from 2009 to 2013. Dr. Acheson graduated from the University of London Medical School in 1980. Following training in internal medicine and infectious diseases in the UK, in 1987 he moved to the New England Medical Center and Tufts University in Boston, Massachusetts. As an Associate Professor at Tufts University, Dr. Acheson undertook basic molecular pathogenesis research on foodborne pathogens, especially Shiga toxin-producing Escherichia coli. In this episode of Food Safety Matters, we speak with David [28:53] about: The U.S. Department of Agriculture's Food Safety and Inspection Service's (USDA's FSIS') declaration of Salmonella as an adulterant in breaded and stuffed raw chicken products, as well as future federal regulation of Salmonella contamination of poultry Considerations that could affect the way in which Salmonella in poultry is regulated, such as different serotypes and the risk they pose to public health The importance of FDA clearly defining for growers what compliance with the agricultural water rule under the Food Safety Modernization Act (FSMA) entails The various, nuanced factors that must be decided in order to adequately regulate ingestible Cannabis products How the federal legal status of Cannabis may hamper foodborne illness reporting and outbreak investigations related to edible Cannabis products Why more effective consumer communication would improve the food recall system, and how recall modernization can achieve that goal How food companies can prepare themselves to meet increasingly stringent aflatoxin regulations—or regulations for any contaminant—through risk assessment, and why regulatory bodies should holistically consider the ramifications of regulations before implementing them Possible avenues that companies and regulatory agencies can take when considering how to reduce human exposure to per- and polyfluoroalkyl substances (PFAS) from foods How chemical residues in foods have been neglected in comparison to microbiological contaminants, and why it is crucial to build scientific understanding around the public health risk of different chemical contaminants. News and Resources USDA-FSIS Proposed Regulatory Framework for Reducing Salmonella in Poultry May Declare Salmonella an Adulterant [3:18] More Research Needed on Exposure To, Toxicity of Microplastics in Food [7:18]International Organizations Develop One Health Action Plan, Food Safety is Key Component [12:18] WHO Launches Global Strategy for Food Safety 2022–2030 [13:08] Edible Sensor for Frozen Food Safety Indicates When Products Have Been Thawed, Refrozen [18:45] Webinar: FDA's Tech-Enabled Traceability—New Standards to Improve Food System Transparency FSIS Proposed Regulatory Framework Microplastics Found in Human Breast Milk for the First Time Former Kerry Inc. Manager Pleads Guilty in Connection with Insanitary Plant Conditions Linked to 2018 Salmonella Poisoning Outbreak CDC: Multistate Outbreak of Salmonella Mbandaka Infections Linked to Kellogg's Honey Smacks Cereal (Final Update) We Want to Hear from You! Please send us your questions and suggestions to podcast@food-safety.com

In this healthcare podcast, we're gonna zoom out and look at the entire healthcare industry. I am very confident that you know a lot about the healthcare industry and its basic stats. It's huge. The healthcare industry is approaching the $4 trillion mark, and it employs more people than any other industry in 47 states. Think about that momentarily. More people work in healthcare than in any other industry in every state except for Wisconsin, Indiana, and Nevada. We could get into (but we won't) how many of the gigantic, consolidated incumbents in the healthcare industry are either for-profits sporting very happy shareholders or investors. Then, of course, we have our “nonprofits”—especially mega-nonprofit health systems—who enjoy some pretty healthy margins while, at the same time, these health systems in general offer up some fairly embarrassing levels of charity care considering the amount of taxes they deprive their communities of. You also are probably eminently familiar with various ways that have been cited to transform the industry. So, the usual suspects here are, of course, changing incentives—offering true value-based care contracts, for example—and then the whole creative destruction angle, wherein upstarts come in with far superior products and services, à la the whole Kodak case study or what happened to Sears and Kmart. Maybe this will happen in healthcare. Other ideas to transform the healthcare industry include employers harnessing the latent power that they have in some markets and then, of course, getting rid of middle people, for sure. Or we could go single payer, of course. That's another suggestion/solution. Today's conversation is a rather holistic look at all of this. I dig into this with David Muhlestein, who is chief research and innovation officer at Health Management Association (HMA). And when I say dig in, I mean dig in. David made some very intriguing points that I had not heard before, actually—and I've heard a lot in my time, so that's saying something. I'm gonna tick off a couple of them, but I don't do them justice. So, you'll need to listen to David explain them and give context. First off, what's the problem with healthcare being a $4 trillion industry in this country—I mean, almost 20% of GDP—and employing more people than any other industry in 47 of our 50 states? There are other big sectors in our economy, after all, that get lots of love. Why is big healthcare “bad” and these other sectors “good” in economic terms when we talk about employment? That's one thing I wanted to know. And David made a point that may be self-evident for some but is worth reiterating in all cases. The government pays for roughly half of healthcare, and from a consumer or just American standpoint, it kind of sucks. I mean, I don't see many Insta selfies of someone rocking their brand-new insurance premium. Dollars going to healthcare or health insurance are not going to consumer goods. And that matters economically as well as retail therapy. For all you econ geeks out there, this industry offers no marginal utility. Here's a second interesting point: Just changing incentives might not be enough. Organizations downstream and upstream need to be on board with the spirit and objective of the incentive change. If they are not, then it's game on for every CFO and their revenue cycle managers to finagle how to find the loophole that enables revenue maximization. Revenue maximization. Period. Revenue. The end. Which brings me to another interesting point: Boards of directors, CEOs, people with fiduciary responsibility … they need to know thyself and consider their actual customer. Spoiler alert: 99% of the time, that actual customer is not patients, no matter what is printed in big letters on the front door. No change can really happen unless those who serve in the upper echelons of these businesses get really real about where their bread is buttered. Organizations are built to serve their customer, after all. So, if a patient isn't identified as a customer, the organization at its very core is gonna have a lot of difficulty serving the patient. So, now what? If I want my organization to move forward in a way that is more patient-centric and less financially toxic, say, what to do? Here's thoughts after chatting with David Muhlestein. Four main steps: As I just said, you gotta get your current state unemotionally understood. For reals, who is the organization built to serve? So, first step is being introspective in the harsh light of day. Consider the timeline of your existential demise. Ha ha, this show is so uplifting. But unless organizations really think out 5 years, 10 years, 25 years and really internalize the existential threat, it's going to be hard to motivate change. I see this all the time. So do you. Inertia is real. Nobody does anything until they absolutely have to. Sidebar: But if you need an eventual demise to bring up at your next strategy meeting, I just saw a paper come out saying that by 2030, cost-related nonadherence could become a leading cause of death in the United States, surpassing diabetes, influenza, pneumonia, and kidney disease. This is as per a study by the nonprofit West Health Policy Center and Xcenda. Nonadherence … what does that mean? It means the patient is not doing their treatment. They are not going to the doctor or getting medical care or not taking their drugs. Meaning no one is making money off of all of those patients, especially when they're dead. This is where the rubber meets all of those excess profits everybody is reaping in the short term. I hope that was helpful for anybody trying to motivate change today.   Consider what legacy we want to leave behind. Do we all want to wait until we're forced to change to do so? Is this the healthcare system we want to leave behind to children and grandchildren? I mean, anybody who's got a loved one in the hospital with anything complex, fighting for their own patient records, on the phone for hours a day with insurance carriers while care is delayed with possibly devastating consequences, the family having to coordinate care and cross their fingers and pray they don't get a ridiculous bill for services that may or may not have been rendered and then use retirement savings to pay for them … if anyone is not looking to be a party to all of this, then let's think about our strategy moving forward and how it will change to meet the future we want to see. On to the evolve and change approaches: How exactly do you think about doing that? According to David Muhlestein, you can repair your current organization or remodel or rebuild. It sounds daunting, but as Dr. Eric Bricker said on our recent interview together (EP351) and as others have said as well, this is already happening in some regions across the country. There are pockets with real transformation. These changes are on the edges right now, but they're showing that this can and is possible.   You can learn more at healthmanagement.com.   David Muhlestein, PhD, JD, is chief research and innovation officer for Health Management Associates (HMA). He is responsible for the firm's self-directed research and supports strategic planning and innovation. David's research and expertise center on healthcare payment and delivery transformation, understanding healthcare markets, and evaluating how the broader healthcare system is changing. He is a self-identified data nerd and regularly speaks and writes about healthcare system evolution. David joined HMA via its acquisition of Leavitt Partners in 2021, where he was the chief strategy and chief research officer. Additionally, David is a visiting policy fellow at the Margolis Center for Health Policy at Duke University, adjunct assistant professor at The Ohio State University College of Public Health, and a visiting fellow at the Accountable Care Learning Collaborative. He previously served as adjunct assistant professor of The Dartmouth Institute (TDI) at the Geisel School of Medicine at Dartmouth College. David earned his PhD in health services management and policy, JD, MHA, and MS from The Ohio State University and a BA from Brigham Young University. 07:38 Is it an issue for the healthcare industry that it is one of the largest employers in the country? 08:42 “I think that we need to figure out what is an appropriate amount to spend on healthcare and get to that level.” 09:01 How do we not decrease the amount of healthcare we're receiving while paying less for that healthcare? 10:11 What are the two ways we can look at decreasing healthcare spend? 15:39 “I think that a regional approach may happen.” 16:56 “When somebody takes less, others are going to follow them.” 17:33 Who is really paying in our current healthcare system? 19:47 “Any sort of a model that you start with influences everything else that you do.” 20:09 What's the common challenge David Muhlestein sees in value-based care systems? 23:21 “There are countless things that you can do to improve the current system today.” 27:25 What are the three options for building up better healthcare? 28:19 David's advice for healthcare executives. 33:22 “To really lower the total cost of … healthcare, it's a 30-year process.” You can learn more at healthmanagement.com.   @DavidMuhlestein discusses #healthcaretransformation on our #healthcarepodcast. #healthcare #podcast #digitalhealth Is it an issue for the healthcare industry that it is one of the largest employers in the country? @DavidMuhlestein discusses #healthcaretransformation on our #healthcarepodcast. #healthcare #podcast #digitalhealth “I think that we need to figure out what is an appropriate amount to spend on healthcare and get to that level.” @DavidMuhlestein discusses #healthcaretransformation on our #healthcarepodcast. #healthcare #podcast #digitalhealth How do we not decrease the amount of healthcare we're receiving while paying less for that healthcare? @DavidMuhlestein discusses #healthcaretransformation on our #healthcarepodcast. #healthcare #podcast #digitalhealth What are the two ways we can look at decreasing healthcare spend? @DavidMuhlestein discusses #healthcaretransformation on our #healthcarepodcast. #healthcare #podcast #digitalhealth “I think that a regional approach may happen.” @DavidMuhlestein discusses #healthcaretransformation on our #healthcarepodcast. #healthcare #podcast #digitalhealth “When somebody takes less, others are going to follow them.” @DavidMuhlestein discusses #healthcaretransformation on our #healthcarepodcast. #healthcare #podcast #digitalhealth Who is really paying in our current healthcare system? @DavidMuhlestein discusses #healthcaretransformation on our #healthcarepodcast. #healthcare #podcast #digitalhealth “Any sort of a model that you start with influences everything else that you do.” @DavidMuhlestein discusses #healthcaretransformation on our #healthcarepodcast. #healthcare #podcast #digitalhealth What's the common challenge David Muhlestein sees in value-based care systems? @DavidMuhlestein discusses #healthcaretransformation on our #healthcarepodcast. #healthcare #podcast #digitalhealth “There are countless things that you can do to improve the current system today.” @DavidMuhlestein discusses #healthcaretransformation on our #healthcarepodcast. #healthcare #podcast #digitalhealth “To really lower the total cost of … healthcare, it's a 30-year process.” @DavidMuhlestein discusses #healthcaretransformation on our #healthcarepodcast. #healthcare #podcast #digitalhealth   Recent past interviews: Click a guest's name for their latest RHV episode! David Scheinker, Ali Ucar, Dr Carly Eckert, Jeb Dunkelberger (EP360), Dan O'Neill, Dr Wayne Jenkins, Liliana Petrova, Ge Bai, Nikhil Krishnan, Shawn Rhodes, Pramod John (EP353), Pramod John (EP352), Dr Eric Bricker, Katy Talento, Stacey Richter (INBW33), Stacey Richter (INBW32), Dr Steve Schutzer (Encore! EP294), Lisa Trumble, Jeb Dunkelberger, Dr Ian Tong, Mike Schneider, Peter Hayes, Paul Simms, Dr Steven Quimby, Dr David Carmouche (EP343), Christin Deacon, Gary Campbell, Kristin Begley  

This is Derek Miller Speaking on Business. More than 10 years ago former Utah Governor Mike Leavitt founded Leavitt Partners to help make healthcare more accessible by developing ideas and recommendations for government and business leaders. Andrew Croshaw is the current CEO and helps us understand the challenges that lie ahead. ANDREW CROSHAW To respond to the Covid crisis, the federal government preserved access to health insurance with federal subsidies, expansions of Medicaid, and funds to local health systems and public health departments. In the coming months we will likely see an end to the designated public health emergency, which means that state officials and business leaders will have to adjust. Some people will lose access to health insurance, so we will need to make both business and policy decisions to determine how, or whether, to stabilize insurance access for individuals and businesses. Fortunately, the state of Utah is taking a bold step towards value-based care, something Mike Leavitt championed since his time as Secretary of Health and Human Services. Leavitt Partners is proud to support this endeavor to ensure all Utahns get the right care at the right time at the right price. Derek Miller Value-based healthcare is a form of reimbursement that ties payments for healthcare delivery to the quality of care provided. By focusing on paying for outcomes rather than procedures, this approach to medicine could significantly reduce overall healthcare costs. I'm Derek Miller, and this is Speaking on Business. Originally Aired: March 21, 2022

James L. Madara, MD, serves as the CEO and executive vice president of the American Medical Association and adjunct professor of pathology at Northwestern University.Dr. Madara has helped sculpt the organization's long-term strategic plan. He also serves as chairman of Health2047 Inc., the wholly-owned innovation subsidiary of the AMA, created to overcome systemic dysfunction in U.S. health care. Prior to the AMA, Dr. Madara spent the first 22 years of his career at Harvard Medical School, receiving both clinical and research training, serving as a tenured professor, and as director of the NIH-sponsored Harvard Digestive Diseases Center. Following five years as chair of pathology and laboratory medicine at Emory University, Dr. Madara served as dean of both biology and medicine, and then as CEO of the University of Chicago Medical Center, unifying the university's biomedical research, teaching and clinical activities. Dr. Madara then served as senior advisor with Leavitt Partners, a health care consulting and private-equity firm founded by former Health and Human Services Secretary Mike Leavitt.Throughout his career, he has published over 200 original papers and chapters and has served as editor-in-chief of the American Journal of Pathology and as president of the American Board of Pathology.Dr. Madara is consistently named one of the nation's 50 most influential physician executives and on the nation's 100 most influential people in health care. Some of his notable awards include the MERIT Award from the National Institutes of Health, the Davenport Award for lifetime achievement in gastrointestinal disease from the American Physiological Society, and the Mentoring Award for lifetime achievement from the American Gastroenterological Society.Welcome to Leading the Rounds!Questions We Asked: What led you to be CEO of the American Medical Association? How did you develop the three arcs of the AMA? What are some targeted things AMA has done to improve physician workflow? What is the goal of Health2047?What does the future of medical education look like? How can medical trainees become involved in innovation in healthcare? What are some book suggestions for medical leaders? Quotes & Ideas: AMA's Three Strategic Arcs: Improving physician satisfaction by removing obstacles that interfere with patient care; Driving the future of medicine by reimagining medical education, training and lifelong learning and by promoting innovation to tackle the biggest challenges in health care; and Improving the health of the nation by leading the charge to prevent chronic disease and confront public health crisesDr. Madara's AMA Startup Health2047 AMA launches Silicon Valley integrated innovation company, Health2047How the AMA works to support medical trainees: AMA announces new online education hub to support lifelong learning, Accelerating Change in Medical EducationThe three legged educational stool: Clinical Science, Basic Science, and Health Systems Science Establish your own personal guiderales. Dr. Madara's include: always take the high road and don't mistake a dropped ball for a conspiracy Book Suggestions: Nudge by Richard H. Thaler Thinking Fast and Slow by Daniel Kahneman

This episode's conversation is about the new Consolidated Appropriations Act (CAA), the fee disclosure part of it, as well as ERISA and the fiduciary responsibility that self-insured employers are responsible to comply with under the law. Don't worry, the first thing my guest in this healthcare podcast, Christin Deacon, does is explain these terms, what they actually mean, and how they can be a tool actually in CEOs' or CFOs' toolboxes to get access to the employer's own claims data, which is a linchpin here that we'll talk about in a sec. But suffice to say here that the ERISA fiduciary responsibility has a few provisions and, in general, self-insured employer health plan administrators kind of tend to off-load worrying about these provisions to their brokers and consultants. The problem with this is that brokers and consultants do not bear the ERISA fiduciary responsibility. They do not bear the responsibility of complying with the CAA either. The employer does. You'd think that, given this, more self-insured employers would dig in hard to do their own due diligence to check whether or not their plan is compliant. But they don't. I asked Parker Edman from Leavitt Partners why, and he said he thought that it's likely a combination of the “old boy's network” and a fear of the massive lift that switching up plan designs or even looking at this might entail. But here's another facet: There's a contingent of plan advisors and carriers who have a very vested interest in self-insured employers not knowing what's going on with their spend. And they actually even have a magic trick that they have developed to beat back inquiries. In this magic trick, HIPAA is the abracadabra. Let me give you an example role-play. Self-insured employer: I need my claims data. Carrier: HIPAA. Self-insured employer: Nooo, not the HIPAA. I stand down. Forget I mentioned it. Here's a pro tip: Actually read HIPAA. Pull it up on your computer. It's easy to find. Spoiler alert: You know what you'll discover? Ninety percent of it is a love note to the carriers themselves that govern the data they must possess and the structure of that data. Ten percent of it is about the privacy of that data, and in that 10%, it specifies clearly that a self-insured employer is a covered entity and, therefore, falls under the umbrella of who can have access to claims data, especially if it is deidentified. Of course, said employer has obligations as to how to treat that data, but yeah, just don't be fooled by the HIPAA when it's wielded like sorcery. The only reason that word has any power is because so many C-suites let it have power. Also now, there's some provisions in the Consolidated Appropriations Act, the CAA (which was passed in 2020), which really ups the ante here. My guest, Christin Deacon, explains all of this and more, including what's up with the CAA, which is good because I could barely remember the name of it throughout the course of this interview. Christin Deacon is a healthcare leader and public-sector entrepreneur. She is a former deputy attorney general, a “recovering attorney” as she calls herself. Earlier this year, 2021, she left her role running the state health and school health benefits plan for about 800,000 New Jersey public employees. Now, she's just transitioned to the private sector where she serves as an executive VP at 4C Health Solutions. You can learn more by emailing Christin at cdeacon@4chealthsolutions.com. You can also connect with her on LinkedIn.   Christin Deacon is a healthcare thought leader who brings with her a wealth of experience in both public and private sector. Driven by her passion to change the healthcare system to truly benefit patients and payers, she focuses on bringing solutions and agency to self-funded and government-sponsored health plans.     04:10 What is ERISA, and what does it stand for? 05:40 What is a fiduciary obligation for an employer? 08:18 “We're now at a point of spending 17.7% of our GDP on healthcare costs.” 09:39 “You absolutely have the keys to … controlling that spend.” 13:35 “You have to own your data.” 15:04 “If you don't have your claims data, how do you know you're paying reasonable fees?” 15:31 “If your carrier is telling you, ‘Oh, HIPAA … you can't look at your data,' you need to pull out that red BS card.” 16:25 How do employers navigate carriers refusing to share claims data? 21:36 “It has only as much teeth as the self-funded employer is … willing to learn about it and … willing to push back.” 22:22 “This is not aspirational; this is an absolute floor.” 24:11 “What does value mean?” 27:41 “Become familiar with HIPAA beyond just the privacy piece.” 29:30 “At the end of the day, it's about people.” 29:38 “If you're not paying reasonable fees, you're using plan assets to enrich others.” 32:21 “The self-insured market … they hold the keys to unlocking value. And they're holding them; they just have to use them.” 34:10 Marshall Allen's new book. You can learn more by emailing Christin at cdeacon@4chealthsolutions.com. You can also connect with her on LinkedIn. @deacon_christin of @4CHealth discusses the #CAA and #ERISA for #selfinsured #employers on our #healthcarepodcast. #healthcare #podcast #digitalhealth What is ERISA, and what does it stand for? @deacon_christin of @4CHealth discusses the #CAA and #ERISA for #selfinsured #employers on our #healthcarepodcast. #healthcare #podcast #digitalhealth What is a fiduciary obligation for an employer? @deacon_christin of @4CHealth discusses the #CAA and #ERISA for #selfinsured #employers on our #healthcarepodcast. #healthcare #podcast #digitalhealth “We're now at a point of spending 17.7% of our GDP on healthcare costs.” @deacon_christin of @4CHealth discusses the #CAA and #ERISA for #selfinsured #employers on our #healthcarepodcast. #healthcare #podcast #digitalhealth “You absolutely have the keys to … controlling that spend.” @deacon_christin of @4CHealth discusses the #CAA and #ERISA for #selfinsured #employers on our #healthcarepodcast. #healthcare #podcast #digitalhealth “You have to own your data.” @deacon_christin of @4CHealth discusses the #CAA and #ERISA for #selfinsured #employers on our #healthcarepodcast. #healthcare #podcast #digitalhealth “If you don't have your claims data, how do you know you're paying reasonable fees?” @deacon_christin of @4CHealth discusses the #CAA and #ERISA for #selfinsured #employers on our #healthcarepodcast. #healthcare #podcast #digitalhealth “If your carrier is telling you, ‘Oh, HIPAA … you can't look at your data,' you need to pull out that red BS card.” @deacon_christin of @4CHealth discusses the #CAA and #ERISA for #selfinsured #employers on our #healthcarepodcast. #healthcare #podcast #digitalhealth How do employers navigate carriers refusing to share claims data? @deacon_christin of @4CHealth discusses the #CAA and #ERISA for #selfinsured #employers on our #healthcarepodcast. #healthcare #podcast #digitalhealth “It has only as much teeth as the self-funded employer is … willing to learn about it and … willing to push back.” @deacon_christin of @4CHealth discusses the #CAA and #ERISA for #selfinsured #employers on our #healthcarepodcast. #healthcare #podcast #digitalhealth “This is not aspirational; this is an absolute floor.” @deacon_christin of @4CHealth discusses the #CAA and #ERISA for #selfinsured #employers on our #healthcarepodcast. #healthcare #podcast #digitalhealth “What does value mean?” @deacon_christin of @4CHealth discusses the #CAA and #ERISA for #selfinsured #employers on our #healthcarepodcast. #healthcare #podcast #digitalhealth “Become familiar with HIPAA beyond just the privacy piece.” @deacon_christin of @4CHealth discusses the #CAA and #ERISA for #selfinsured #employers on our #healthcarepodcast. #healthcare #podcast #digitalhealth “At the end of the day, it's about people.” @deacon_christin of @4CHealth discusses the #CAA and #ERISA for #selfinsured #employers on our #healthcarepodcast. #healthcare #podcast #digitalhealth “If you're not paying reasonable fees, you're using plan assets to enrich others.” @deacon_christin of @4CHealth discusses the #CAA and #ERISA for #selfinsured #employers on our #healthcarepodcast. #healthcare #podcast #digitalhealth “The self-insured market … they hold the keys to unlocking value. And they're holding them; they just have to use them.” @deacon_christin of @4CHealth discusses the #CAA and #ERISA for #selfinsured #employers on our #healthcarepodcast. #healthcare #podcast #digitalhealth Gary Campbell, Kristin Begley, David Contorno (AEE17), David Contorno (EP339), Nikki King, Olivia Webb, Brandon Weber, Stacey Richter (INBW30), Brian Klepper (AEE16), Brian Klepper (EP335), Sunita Desai, Care Plans vs Real World (EP333), Dr Tony DiGioia, Al Lewis, John Marchica, Joe Connolly, Marshall Allen, Andrew Eye, Naomi Fried, Dr Rishi Wadhera, Dr Mai Pham, Nicole Bradberry and Kelly Conroy, Lee Lewis, Dr Arshad Rahim, Dr Monica Lypson, Dr Rich Klasco, Dr David Carmouche (AEE15), Christian Milaster

Former HHS Secretary and 14th Governor of Utah, Mike Leavitt, joins the show to discuss why value-based care is something that both the Dems and GOP can get behind. Visit us at www.caretalkpodcast.comWatch this episode on YouTube: https://youtu.be/vGLhS_4D-L4Subscribe to CareTalk on your favorite podcast service:Spotify https://open.spotify.com/show/2GTYhbN......Apple Podcasts https://podcasts.apple.com/us/podcast......Google Podcasts https://podcasts.google.com/feed/aHR0...... About Mike Leavitt:Mike Leavitt is the founder of Leavitt Partners where he helps clients navigate the future as they transition to new and better models of care. In previous roles, Mike served in the Cabinet of President George W. Bush (as Administrator of the Environmental Protection Agency and Secretary of Health and Human Services) and as a three-time elected governor of Utah.#ValueBasedCare #Healthcare #HealthcarePolicy #HealthInsurance

Host Dr. Nick van Terheyden aka Dr. Nick talks Frictionless Access to Digital Health Information, with Ryan Howells Principal at Leavitt Partners. Discussions include protecting patients and clinical data, creating trust and verifiable identities in healthcare, and vaccine credential initiative. To stream our Station live 24/7 visit www.HealthcareNOWRadio.com or ask your Smart Device to “….Play HealthcareNOW Radio”. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

This week Spencer sits down with Rich Mckeown, co-founder of Leavitt Partners and former chief of staff to Governor Mike Leavitt. They discuss the end of Utah's Legislative session, Governor Cox's promise to veto more bills than his predecessor, how to pronounce sine die, and more! 

Dr. David Acheson is the President and CEO of the Acheson Group; David has had a long and distinguished career in the food industry, probably best known for his work with the FDA where he held several positions including Associate Commissioner for Foods, which gave him an agency-wide leadership role for all food and feed issues, including health promotion and nutrition. After his time with the FDA, Dr. Acheson was a partner at Leavitt Partners and managed Leavitt Partners Global Food Safety Solutions.  In 2013 he founded The Acheson Group, a consulting firm which provides strategic advice as well as recall and crisis management support to food companies and ancillary technology companies on a global basis on all matters relating to food safety and food defense. Dr. Acheson works with many food and beverage companies globally to assist them in managing the complexity of modern food safety. This includes both well-established global companies as well as technology providers, startup businesses, and private equity firms.  Dr. Ben Katchman leads the research and development of sample preparation and assay development at PathogenDx, a Scottsdale, AZ-based company which provides disruptive DNA-based pathogen testing technology and solutions for the cannabis, botanical, food, and agricultural industries. Prior to joining PathogenDx, Dr. Katchman was a Principle Investigator at Eccrine Systems, where he led all clinical research, regulatory pathway implementation, assay development, and biomarker studies. He was also the co-founder of FlexBioTech, where he led the development of novel OLED-based molecular diagnostic assay platforms. Dr. Katchman received a Bachelor of Science degree in Microbiology, from Indiana University before carrying out graduate research at Arizona State University. In this BONUS episode of Food Safety Matters, we speak to Dr. David Acheson and Ben Katchman, Ph.D. about: Environmental monitoring through the regulatory lens and the advent of the ‘Swabathon’ Root causes of microbiological contamination in processing plants David Acheson describes what impressed him about PathogenDxs’ solutions Overview of EnviroX-F technology Time and cost savings associated with a single test solution Shifting the science of food safety from microbiology to molecular biology techniques The critical role of environmental monitoring managing risk in food processing Sponsored by: PathogenDx For more information on PathogenDx’s simple, powerful and inexpensive DNA-based pathogen testing, visit www.pathogendx.com.

ACOs are increasingly moving into two-sided risk options with MSSP BASIC E and ENHANCED. The Direct Contracting model (with both Professional and Global options) introduces new opportunities and flexibilities that are not included in other CMMI models or through the MSSP. Prospective participants must act now to evaluate their model options in preparation for the 2022 performance year, with both MSSP and DC application cycles quickly approaching. CMS will soon reopen the MSSP for the 2022 performance year, and the application period for DC's second and final cohort is also expected to open around in Spring 2021, according to CMMI's latest timeline.  Now is the time for organizations to evaluate options and make decisions.  To aid in that analysis and decision-making, the ACLC and Lumeris partnered together to develop an intelligence brief (coming soon) that is also the focus of this podcast episode. The brief is designed to help provider organizations who are ready to take on significant levels of downside risk to judiciously evaluate the available options, consider the general opportunities and risk associated with the models, compare the methodological differences between MSSP BASIC Level E and MSSP ENHANCED with DC Professional and DC Global, and assess organizational fit. We share detailed comparisons across 7 key areas:   Participant Eligibility  Beneficiary Attribution  Financial Benchmarking  Quality Performance  Payment Models  Financial Settlement   Additional Benefits  Our guest this week is Rick Goddard, Senior Director of Market Strategy at Lumeris. Rick is a subject matter expert on value-based payment models and primarily serves as an enterprise strategist. Prior to joining Lumeris, Rick served as the Director of Clinical Innovation at Advocate Physician Partners / Advocate Health Care where led the Clinical Innovation Team. His in-depth operational and consulting experience makes him the perfect guest to help organizations considering their next step on this race to value!  (Information coming from CMS is ongoing and any opinions are not necessarily those of Lumeris, the Accountable Care Learning Collaborative, or our research associate Leavitt Partners.) Access the transcript for this episode here. Glossary of Acronyms: MSSP – Medicare Shared Savings Program ACO – a contracted entity in the MSSP DC – Direct Contracting (new CMMI payment model) DCE – a contracted entity in the DC model APM – Alternative Payment Model MA – Medicare Advantage CMS – Centers for Medicare and Medicaid Services CMMI – Center for Medicare and Medicaid Innovation TIN – Tax ID# (ACO participants in the MSSP are contracted by TIN) NPI – National Provider ID # (DCE participants are contracted by the individual NPI)   Episode Bookmarks: 4:50 Rick Goddard explains his personal connection with mental health and how that informs his “Why” 6:00 Finding balance and lessons learned from training for the Ironman World Championship 7:00 “What excites me is that value is starting to get momentum in the environment, and that thaws out providers and forces them into the game.” 8:50 The accomplishments of the MSSP (growth, building a bridge to risk, and $2B in savings to date) 11:30 The early years of the Pioneer and MSSP ACO programs and what we learned as an industry 12:30 “The upside-only ACO opportunity didn't have the teeth, nor did the program offer effective levers for us to succeed in managing the total cost of care.” 12:40 MSSP Challenges (e.g. beneficiary complaints and CCLF opt-outs, delays in data sharing, “black box” reconciliation) 14:00 “There weren't enough managed care-like designs to assist MSSPs to progress in risk.” 14:40 CMS offering incentives for ACOs to accept risk (e.g. SNF 3-day rule, Telehealth waivers, an availability to work with a prospective attribution model) 15:00 “Up until the Next Generation ACO,

As we prepare for a new era in our government with President-Elect Biden's administration and a Democratic-controlled Congress, we must be steadfast in our commitment to value-based care. Can soon-to-be President Biden capitalize on this historical moment of unrest to unite our country with a value-based care policy agenda? Is COVID-19 truly a silver-lining moment for the value movement? How will providers, payers, policy-makers, public health, and patients leverage increased regulatory flexibilities, technological innovations, and major cultural shifts to fast-track strategic priorities that support the triple aim? Our guest this week is Andrew Croshaw, Chief Executive Officer of Leavitt Partners. Andrew's insights inspire and inform. Supported by leading-edge health care value economy research and intelligence from Leavitt Partners, this episode will provide you with the best policy analysis out there on this “Race to Value.” For additional information on the topics discussed in this episode, make sure to download the latest ACLC Intelligence Brief, The Future of Value-Based Care: 2021 and Beyond. Episode Bookmarks: 1:40 A nation's sadness due to recent events that have unfolded in Washington, D.C., and hope for a peaceful transfer of power in our democratic republic 2:40 Value-Based Care in the new era of government with President Biden's administration and a Democratic-controlled Congress 3:13 How the value movement will allow us to improve population health and remain competitive in a global marketplace 3:40 The moral and economic imperative to make value-based care work 4:34 Referencing the newly-released ACLC Intelligence Brief entitled, “The Future of Value-Based Care: 2021 and Beyond” 6:20 Andrew's personal reflection on the recent violence at our nation's Capitol and the need for human connection and civility 7:10 How lack of accountability and the divisiveness of social and mainstream media creates incivility and violence 8:40 Hope for a moment for renewal and a better tomorrow 8:53 How the recent Georgia runoff election, giving control of the Senate to Democrats, will enable additional pathways for President Biden's health policy agenda 9:12 Progress independent of any bipartisanship with elements of the health policy agenda that will still require bipartisan support 10:00 Passage of legislation in the Senate with a budget maneuver called “reconciliation” that can allow legislators to pass certain bills with a bare majority of votes (not the typical 60 votes required) 10:27 “I am encouraged for a sense of bipartisanship based on us learning how precious and fragile we now realize stability in our country really is.” 11:50 COVID-19 emphasizing the need for significant payment and delivery transformation, showcasing the advantages of prospective, non-FFS-based alternative payment models 12:20 Leavitt Partners' monitoring of public and private sector value-based contracts showing that “Value-based contracts continued in 2020 despite the pandemic.” 13:15 Increase private sector focus on value-based payment (e.g. bundles, specialty ACO models, traditional ACO contracts) 13:27 Medicare Advantage, as a segment of value-based care, showing significant growth and newly-emerging plans are working well for beneficiaries and sponsor 14:12 Large employer advocacy of value-based care and how their voice will continue to grow louder 14:52 Startups forming meaningful partnerships with employers in the value space and how that will be disruptive over time 16:05 The promise of high-touch, full-risk primary care organizations (like ChenMed) as an important driver of value transformation and an influencer of health policy reform 17:20 “One of the benefits of 2020 was that it did highlight the benefit of taking risk to primary care providers. (I am a little afraid, also, of what that signaled to payers.)” 17:30 Historical reluctance of payers delegating risk and how th...

This is Derek Miller Speaking on Business. As the coronavirus continues to challenge our state and nation, Leavitt Partners is helping clients address the pressing conditions of today while preparing for the future of the healthcare industry. CEO of Leavitt Partners, Andrew Croshaw, is here to tell us what the company is doing. ANDREW CROSHAW As the impacts of the Coronavirus pandemic reached Utah, Leavitt Partners worked with the University of Utah David Eccles School of Business to develop and launch a multi-week, virtual educational series focused on helping Utah businesses navigate COVID-19. During that same period, we also provided support to the State of Utah to create measures and guidelines to help avoid large scale shutdowns. This support included quarantine guidelines for asymptomatic individuals and households, as well as guidelines for those living with individuals that have symptoms. Leavitt Partners continues to support the Utah Department of Health with innovative approaches to improve the health and wellness of the entire community, including our underserved populations. We understand that COVID-19 is reshaping the healthcare industry, which is why we are working with businesses in Utah and across the country to safely and successfully operate in the new normal. DEREK MILLER Leavitt Partners is a great example of the kinds innovative efforts and engaged teamwork taking place throughout Utah to reduce the impact of COVID-19 on health and financial well-being. More details are available at leavittpartners.com. I'm Derek Miller with the Salt Lake Chamber, and this is Speaking on Business. Originally Aired: November 11, 2020.

In today's episode, we chat over Zoom with Nikki Campbell, Director at Utah Department of Health, and Senior Director at Leavitt Partners- a nationwide leader in healthcare consulting and management services, John Poelman, about All Aggies Doing Their Part This Fall by Following the Utah Health Guidelines. Nikki Campbell and John Poelman have been on the Utah Phased Guidelines workgroup since its inception. These Utah Phased Guidelines have been crucial in ensuring the health of our Aggie Family and Cache Valley, Utah community. coronavirus.utah.govready.usu.eduusu.edu/covid-19

Wouldn’t you love to be a fly on the wall during the discussions happening at the federal level? In this episode of GYDFS, we bring you Rich McKeown, former chief of staff to secretary Mike Leavitt at the US Department of Health & Human Services (HHS) and co-founder of Leavitt Partners. During his work at HHS during the Bush administration, Rich led the negotiations between China & the FDA and helped pave the way for the placement of FDA offices around the world. Tune in to hear the inside scoop from the hallways of HHS & some expert opinions on our country’s pandemic preparedness.

In this episode of Managed Care Cast, we speak with the lead author of a study in the May issue of The American Journal of Managed Care® about the shift in new accountable care organizations (ACOs) from being led by hospital systems to being led by physician groups, and the accompanying policy shifts that are needed. David Muhlestein, the chief strategy and chief research officer at Leavitt Partners, also discussed his thoughts on the affect of coronavirus disease 2019 on ACOs. The study is titled "Accountable Care Organizations Are Increasingly Led by Physician Groups Rather Than Hospital Systems."

Dr. David Acheson, is the founder and CEO of The Acheson Group and brings more than 30 years of medical and food safety research and experience to provide strategic advice as well as recall and crisis management support to food companies and ancillary technology companies on a global basis on all matters relating to food safety and food defense.   David graduated from the University of London Medical School and practiced internal medicine and infectious diseases in the United Kingdom until 1987 when he moved to the New England Medical Center and became an Associate Professor at Tufts University in Boston, studying the molecular pathogenesis of foodborne pathogens.   Prior to forming The Acheson Group, David served as the Chief Medical Officer at the U.S. Department of Agriculture Food Safety and Inspection Service and then joined the U.S. Food and Drug Administration (FDA) as the Chief Medical Officer at the FDA Center for Food Safety and Applied Nutrition (CFSAN). After serving as the director of CFSAN’s Office of Food Defense, Communication, and Emergency Response, David was appointed as the Assistant and then Associate Commissioner for Foods, which provided him an agency-wide leadership role for all food and feed issues and the responsibility for the development of the 2007 Food Protection Plan, which served as the basis for many of the authorities granted to FDA by the Food Safety Modernization Act.   From 2009 to 2013, he was a partner at Leavitt Partners where he managed Leavitt Partners Global Food Safety Solutions.  David has published extensively and is internationally recognized both for his public health expertise in food safety and his research in infectious diseases. He is a sought-after speaker and regular guest on national news programs. He serves on a variety of boards and food safety advisory groups of several major food manufacturers. David was previously a guest on Food Safety Matters – episodes 12 and 45. In this episode of Food Safety Matters, we speak to David [11:31] about: Classifying RTE foods and how consumer behavior plays a critical role Challenges related to messaging and marketing tactics displayed on consumer packaging and how it can interfere with food safety perception Consumer vs. manufacturer responsibility when foodborne illness occurs How food processing trends, consumer behaviors, and regulations intertwine Steps a company can take to determine if their product is truly RTE Why consistently negative swabbing results is not a good thing How FDA responds to positive contamination findings in a plant The challenges associated with drilling down traceability to the item level Romaine lettuce and why leafy greens are such a tricky commodity Salmonella and the likelihood that it may officially become an adulterant David Acheson's Contributions to Food Safety Magazine Managing Risks in the Global Supply Chain  What Have We Learned about FSMA Implementation?  Are All Salmonella Created Equal? New Directions in Food Protection   ​Resource: Blog: What Does Marler's Salmonella Citizen Petition Mean to You? News Mentioned in This Episode USA Today: Inspections, Citations, Recalls Slashed: Coronavirus is Testing America's Food Safety Net [4:17] LGMA: Work Underway to Further Strengthen Food Safety Practices for Leafy Greens [9:19] LeafyGreenGuidance.com Keep Up with Food Safety Magazine Follow Us on Twitter @FoodSafetyMag and on Facebook  Subscribe to our magazine and our biweekly eNewsletter We Want to Hear From You! Please share your comments, questions, and suggestions. Tell us about yourself—we'd love to hear about your food safety challenges and successes. We want to get to know you! Here are a few ways to be in touch with us. Email us at podcast@foodsafetymagazine.com Record a voice memo on your phone and email it to us at podcast@foodsafetymagazine.com

US states are taking the lead in managing the COVID-19 pandemic. What can state governors expect from the federal government and from the US Department of Health and Human Services? Governor Mike Leavitt from Leavitt Partners joins JAMA Editor Howard Bauchner, MD, in this live Q&A. Recorded April 8, 2020.

US states are taking the lead in managing the COVID-19 pandemic. What can state governors expect from the federal government and from the US Department of Health and Human Services? Governor Mike Leavitt from Leavitt Partners joins JAMA Editor Howard Bauchner, MD, in this live Q&A. Recorded April 8, 2020.

Mike Leavitt served in the Cabinet of President George W. Bush, first as the Administrator of the Environmental Protection Agency and then as Secretary of Health and Human Services. Before this, he served as a three-time elected governor of Utah. He is also the founder of Leavitt Partners, a health care intelligence business.When Governor Mike Leavitt was HHS Secretary a colleague tossed a book on his desk: a History of the 1918 pandemic, saying to study it. He then threw another book on the desk, saying "or there will be one of these", which was a congressional inquiry. Leavitt read the books. Trump hasn't. Michael and governor Leavitt discuss.

Focusing on interoperability and how customers can gain access to the data For the show notes, full transcript, links, and resources please visit us at show link: https://bit.ly/2k2Y8a2

This is a special podcast from the National Association of Chronic Disease Directors’s 2019 Chronic Disease Academy. Leavitt Partners experts Bo Nemelka, Susan Winkler, and Andrew Croshaw will discuss “The Future of Value-Based Health,” where they will share their predictions for the near and long-term future of healthcare and health policy.

Dr. David Acheson, is the founder and CEO of The Acheson Group and brings more than 30 years of medical and food safety research and experience to provide strategic advice as well as recall and crisis management support to food companies and ancillary technology companies on a global basis on all matters relating to food safety and food defense.   David graduated from the University of London Medical School and practiced internal medicine and infectious diseases in the United Kingdom until 1987 when he moved to the New England Medical Center and became an Associate Professor at Tufts University in Boston, studying the molecular pathogenesis of foodborne pathogens.   Prior to forming The Acheson Group, David served as the Chief Medical Officer at the U.S. Department of Agriculture Food Safety and Inspection Service and then joined the U.S. Food and Drug Administration (FDA) as the Chief Medical Officer at the FDA Center for Food Safety and Applied Nutrition (CFSAN). After serving as the director of CFSAN’s Office of Food Defense, Communication, and Emergency Response, David was appointed as the Assistant and then Associate Commissioner for Foods, which provided him an agency-wide leadership role for all food and feed issues and the responsibility for the development of the 2007 Food Protection Plan, which served as the basis for many of the authorities granted to FDA by the Food Safety Modernization Act.   From 2009 to 2013, he was a partner at Leavitt Partners where he managed Leavitt Partners Global Food Safety Solutions.  David has published extensively and is internationally recognized both for his public health expertise in food safety and his research in infectious diseases. He is a sought-after speaker and regular guest on national news programs. He serves on a variety of boards and food safety advisory groups of several major food manufacturers.   In this episode of Food Safety Matters, we speak to David [32:48] about: The food industry's hesitation about speaking openly about food safety and the science behind it Consumers' lack of trust and understanding when it comes to food science How the media plays a role in shaping consumer attitudes about food safety Scientists and their traditional lack of ability to effectively communicate with consumers  The state of food safety today vs. years/decades ago Why it makes sense that today's food supply is safe despite an increasing number of recalls and outbreaks Balancing science, public health, consumer demand, and marketing messages The top misperceptions that consumers have about food We also speak with Hilary Thesmar (Food Marketing Institute) and Shelley Feist (The Partnership for Food Safety Education) [12:03] about: The recent 2019 Consumer Food Safety Education Conference How food processors and manufacturers benefit from the conference  How consumer food safety messaging is continuously improving Consumer behavior that goes against standard food safety practices Support from BAC Fighters Articles by David Acheson in Food Safety Magazine Why Don't We Learn More from Our Mistakes? Industry Perspectives of Proposed FSMA Rule on Preventive Controls News Mentioned in This Episode USDA FSIS Issues Meat Industry Best Practices for Responding to Customer Complaints [2:34]  Bumble Bee Tuna Using Blockchain Technology to Trace Fish Origin for Consumers [4:55]  Strawberries, Spinach, and Kale Top 2019 Dirty Dozen List [8:14] Keep Up with Food Safety Magazine Follow Us on Twitter @FoodSafetyMag and on Facebook  Subscribe to our magazine and our biweekly eNewsletter We Want to Hear From You! Please share your comments, questions, and suggestions. Tell us about yourself—we'd love to hear about your food safety challenges and successes. We want to get to you know you! Here are a few ways to be in touch with us. Email us at podcast@foodsafetymagazine.com Record a voice memo on your phone and email it to us at podcast@foodsafetymagazine.com

About 61%, or approximately 2 million Utahns, purchase health insurance through employers. This is the highest in the nation and significantly higher than the U.S. average of 49%. For this reason, it is critical that Utah's employers play a larger role in the future of our state's health care system and have more flexibility and control in costs. In this Building Utah podcast, we sit down Andrew Croshaw, CEO of Leavitt Partners and co-chair of the Salt Lake Chamber's health systems reform committee to talk about the Chamber's 2019 legislative priorities that focus on health care.

Andréa Caballero speaks with David Muhlestein, Chief Research Officer at Leavitt Partners, about his latest research titled "Growth of Population-Based Payments is Not Associated With a Decrease in Market-Level Cost Growth, Yet." They discuss what really dictates good competition within a health care market, how much revenue is necessary to make a business case for reforming a delivery system, and what kinds of evaluations are needed to scale and inform the next generation of payment reform programs. Link to report: https://leavittpartners.com/whitepaper/growth-of-population-based-payments-is-not-associated-with-a-decrease-in-market-level-cost-growth-yet/

Nato Allies have met in Brussells. President Trump visits America’s long-time ally in Great Britain and meets with Americas long-time rival Russian President Vladimir Putin. Trade wars and tariff battles continue while bad actors, dictators, and terrorists threaten world peace. For leaders today, finding allies and building alliances has never been more vital. Guest: Rich McKeown Rich McKeown co-founder of Leavitt Partners and author of "Finding Allies, Building Alliances," is our guest. McKeown served as Chief-of-Staff for Mike Leavitt at the U.S Department of Health and Human Services.

Focusing on interoperability and how customers can gain access to the data

The 2018 ballot is coming into focus as political conventions are held and ballot initiative groups submit their signatures. The Legislature will vote on overriding Gov. Herbert's vetoes in a special session..  The Salt Lake Tribune's Jennifer Napier-Pearce, The Deseret News' Boyd Matheson, and Rich McKeown of the Leavitt Partners discuss these and other topics on this week's Hinckley Report.

In this episode, David Muhlestein, Chief Research Officer at Leavitt Partners discusses a recent report issued by Leavitt Partners that examined the relationship between the concentration of Medicare Advantage plans in a market and Medicare Advantage premiums. Learn how to listen to The Hospital Finance Podcast on your mobile device. Mike Passanante: Hi, this is Mike Passanante. And welcome Read More

Dr. David Acheson, M.D., is the founder and CEO of The Acheson Group and brings more than 30 years of medical and food safety research and experience to provide strategic advice as well as recall and crisis management support to food companies and ancillary technology companies on a global basis on all matters relating to food safety and food defense.   David graduated from the University of London Medical School and practiced internal medicine and infectious diseases in the United Kingdom until 1987 when he moved to the New England Medical Center and became an Associate Professor at Tufts University in Boston, studying the molecular pathogenesis of foodborne pathogens.   Prior to forming The Acheson Group, David served as the Chief Medical Officer at the U.S. Department of Agriculture Food Safety and Inspection Service (FSIS) and then joined the U.S. Food and Drug Administration (FDA) as the Chief Medical Officer at the FDA Center for Food Safety and Applied Nutrition (CFSAN). After serving as the director of CFSAN’s Office of Food Defense, Communication and Emergency Response, David was appointed as the Assistant and then Associate Commissioner for Foods, which provided him an agency-wide leadership role for all food and feed issues and the responsibility for the development of the 2007 Food Protection Plan, which served as the basis for many of the authorities granted to FDA by the Food Safety Modernization Act (FSMA).   From 2009 to 2013 he was a partner at Leavitt Partners where he managed Leavitt Partners Global Food Safety Solutions.  David has published extensively and is internationally recognized both for his public health expertise in food safety and his research in infectious diseases. He is a sought-after speaker and regular guest on national news programs. He serves on a variety of boards and food safety advisory groups of several major food manufacturers. In this episode of Food Safety Matters, we speak to David Acheson about: His role in building the 2007 Food Protection Plan and how it parallels FSMA The importance of the food safety crises that took place in 2006 and 2007 The differences between food fraud, food security, food defense and food adulteration, and how sometimes these instances do not necessarily implicate a public health risk His advice to food companies gearing up to comply with FSMA's food defense regulations Facing the realities of determining whether your food plant is at risk of committing a food-related crime How to advocate for more or better resources, and how to convince the C-suite to invest in food safety Balancing food safety goals with a company's other metrics—sales, margins, etc. The main challenges he sees facing food companies His views on announced vs. unannounced audits How the Peanut Corporation of America debacle helped shape FSMA's Preventive Controls rule and how it forced some food companies to rebuild their own supply and control programs His thoughts on how legal roadblocks keep food safety violations from ever coming to light Articles by David Acheson in Food Safety Magazine Why Don't We Learn More from Our Mistakes? https://www.foodsafetymagazine.com/magazine-archive1/junejuly-2014/why-dont-we-learn-more-from-our-mistakes/ Industry Perspectives of Proposed FSMA Rule on Preventive Controls https://www.foodsafetymagazine.com/magazine-archive1/aprilmay-2013/industry-perceptions-of-proposed-fsma-rule-on-preventive-controls/ News Mentioned in This Episode FDA Reminds Public of Soy Nut Butter Recall https://www.foodsafetymagazine.com/news/fda-reminds-public-of-soy-nut-butter-recall/ Opponents Say USDA Reorganization has Multiple Problems http://www.foodsafetynews.com/2017/10/opponents-say-usda-reorganization-has-multiple-problems/#.We5sGpOnHUJ Raw Milk Dairy Out of Time to Appeal Retail License Suspension http://www.foodsafetynews.com/2017/10/raw-milk-dairy-out-of-time-to-appeal-retail-license-suspension/#.WeoVEhNSygR Why Is it So Hard to Track the Source of a Food Poisoning Outbreak? https://www.bostonglobe.com/magazine/2017/10/11/why-hard-track-source-food-poisoning-outbreak/6RD8EJru631SldqXHFx9mK/story.html Food Truck Commissary: The Foundation of a Mobile Business https://www.foodsafetymagazine.com/magazine-archive1/junejuly2016/food-truck-commissary-the-foundation-of-a-mobile-business/ Savor Safe Street Food https://www.foodsafetymagazine.com/magazine-archive1/junejuly-2015/savor-safe-street-food/

Tuesday, October 3rd our special guest on This Week in Accountable Care Leavitt Partners, Chief Research Officer David Muhlestein, PhD, JD joins Andre Berger, MD and Alex Foxman, MD for a 'pulse check' on the accountable care industry including key insights from a recent publication: Medicare Alternative Payment Models: Not Every Provider Has a Path Forward. More about David: David Muhlestein, PhD, JD, is Chief Research Officer based in Washington, DC.  He directs the study of accountable care organizations through the LP Center for Accountable Care Intelligence and leads the firm’s quantitative evaluation of health care markets. He is an expert in using policy analysis, predictive modeling, and applied analytics to understand the evolving health care landscape. David also serves as Adjunct Assistant Professor of The Dartmouth Institute (TDI) at the Geisel School of Medicine at Dartmouth College, is a Visiting Policy Fellow at the Margolis Center for Health Policy at Duke University, and is a Visiting Fellow at the Accountable Care Learning Collaborative.  In these roles he conducts research to translate learnings of high-performing organizations for the benefit of the broader health care system. Join National ACO co-founders Drs. Andre Berger and Alex Foxman for an informative exploration!

Tuesday, October 3rd, Leavitt Partners, Chief Research Officer David Muhlestein, PhD, JD joins Andre Berger, MD and Alex Foxman, MD for a 'pulse check' on the accountable care industry including key insights from a recent publication: Medicare Alternative Payment Models: Not Every Provider Has a Path Forward. More about David: David Muhlestein, PhD, JD, is Chief Research Officer based in Washington, DC.  He directs the study of accountable care organizations through the LP Center for Accountable Care Intelligence and leads the firm’s quantitative evaluation of health care markets. He is an expert in using policy analysis, predictive modeling, and applied analytics to understand the evolving health care landscape. David also serves as Adjunct Assistant Professor of The Dartmouth Institute (TDI) at the Geisel School of Medicine at Dartmouth College, is a Visiting Policy Fellow at the Margolis Center for Health Policy at Duke University, and is a Visiting Fellow at the Accountable Care Learning Collaborative.  In these roles he conducts research to translate learnings of high-performing organizations for the benefit of the broader health care system. Join us!

Jon Huntsman, Jr. breezes through his Senate confirmation hearing, Secretary Zinke's memo on shrinking national monuments is leaked, and the legislature meets in a special session to tackle homelessness. The Kem C. Gardener Policy Institute's Natalie Gochnour, Leavitt Partners' Chairman Rich McKeown, and the AP's Michelle Price join Jason Perry for this week's show.

Here’s how fast things are moving in health care: Mike Leavitt, who ran HHS under President George W. Bush, came to Washington 10 days ago to testify about the need for bipartisan health reforms — and since that day, when he sat down with POLITICO's Dan Diamond, the Senate’s bipartisan health push has collapsed and the GOP’s latest Obamacare repeal bill is on life support. Although the conversation is slightly dated, the former HHS secretary is a must-listen voice on health care issues, and he shares his perspective on possible health reforms (starts at the 16:30 mark), his pessimism on Medicare-for-all (22:00), his concerns about the Affordable Care Act (25:15) and his post-government work as head of Leavitt Partners (32:30). But first, POLITICO’s Rachana Pradhan and Jennifer Haberkorn join PULSE CHECK to break down the wild week in health care (starts at the 2:15 mark) and Rachana and Dan’s reporting about HHS Secretary Tom Price’s charter jets — an investigation that made this podcast so delayed (starts at 8:55 mark). We’d appreciate your help: Please share PULSE CHECK and rate us on your favorite podcast app! Have questions, suggestions or feedback? Email ddiamond@politico.com. Stories referenced on the podcast: Jen's story with colleagues on Sen. John McCain's decision to oppose ACA repeal again: http://www.politico.com/story/2017/09/22/mccain-to-oppose-graham-cassidy-likely-sinking-obamacare-repeal-243028?lo=ap_a1 Dan and Rachana’s investigation into Tom Price's use of charter planes: http://www.politico.com/story/2017/09/19/tom-price-chartered-planes-flights-242908 Rachana and Dan's follow-up on Price's 24 charter flights since May: http://www.politico.com/story/2017/09/21/tom-price-private-charter-plane-flights-242989

David is the Chief Development Officer where he is responsible for expanding the firm's influence in the health care market. Since joining Leavitt Partners, David has advised clients in areas of government activity, insurance market reforms, economic changes to the health care payment system, and alliances. He specifically helped establish the Private Exchange Coalition and has led multiple other collaboratives that aggregate parties with common interests to achieve statutory, regulatory, or market objectives. David also established and expanded Leavitt Partners Chicago operation. David has a masters of statistics with an emphasis in econometrics from the University of Utah. He also served on the Utah State Board of Regents, where he shared some collective stewardship over Utah's publicly funded institutions of higher education. 00:00 The inexorable shift from FFS to Value-Based Care. 02:00 Dispassionate Economics. 02:30 Where David thinks Healthcare will be in one year. 03:45 Consumerism and Consumer choice in Healthcare. 04:20 Information Asymmetry. 06:00 Decision making in Healthcare as a Consumer and as a Patient. 07:50 Trends moving forward. 08:20 The changing nature of physician roles. 10:30 Harnessing Data. 12:45 Where Practice Transformation begins to matter. 15:40 Core themes for successful futures. 16:45 Defining Value. 17:20 Build for Value. 18:00 Build for and around the Patient. 18:40 Adding value to the system. 19:20 Becoming more collaborative. 21:00 Setting Value. 23:00 Creating Value by driving adoption through CMS. 24:15 Three questions for Health Tech Startups. 28:00 Health Policy. 30:00 You can find out more information at www.leavittpartners.com.

Listen NowHealth care payment is solidly moving, or moving once again, toward pay for value or value-based contracting.  This means a health care provider's reimbursement is incented or tied to a predetermined (typically annual) financial amount and/or is based on attaining certain quality care metrics.   The Medicare Shared Savings Program and private sector "accountable care organizations" are both endeavoring to lower health care cost growth and improve quality and patient outcomes via these value or performance-based contracts.  During this 21-minute discussion Dr. David Muhlestein describes the various types of pay for value contract arrangements including use of quality metrics, what types of providers sign these contracts, what have the results been to date, the keys to success or what are the challenges in succeeding under these agreements and potential downsides for providers and/or patients .   David Muhlestein is the Senior Director of Research and Development at Leavitt Partners (LP).  He directs LP's study of pay for value and accountable care contracting through LP's Center for Accountable Care Intelligence and leads the firms' quantitative evaluation of health care markets. He is an expert in using policy analysis, predictive modeling and applied analytics to understand the evolving health care landscape.  His insights have been quoted by publications including The Wall Street Journal, The Seattle Times and Modern Healthcare.  David earned his Ph.D. at Ohio State University and his JD at Ohio State's Moritz College of Law.   For information regarding Leavitt Partners' related work see: http://leavittpartners.com/solutions/. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit www.thehealthcarepolicypodcast.com

On the Wednesday, November 30th, 2011 broadcast at 11AM PT/2PM ET my special guests include two principal co-authors of the recently released Leavitt Partners study titled: Growth and Dispersion of Accountable Care Organizations'. For an abstract and link to download the full report, click here. More about the guests: Andrew Croshaw is Managing Director, Health Care Practice, at Leavitt Partners. Founded by former U.S. Health and Human Services Secretary and EPA Administrator Michael O. Leavitt, the partnership advises clients in the health care and food safety sectors. As Managing Director of the Health Care Practice, Croshaw helps clients enter new markets, enhance the value of their products, navigate dynamic regulatory and reimbursement systems and improve health conditions around the world.   Thomas Merrill is a strategic analyst at Leavitt Partners.  As a member of the knowledge development team, Merrill collaborates with others to analyze and research issues associated with health reform and more specifically, emerging care models and the various factors that influence the modern health care landscape. We'll discuss the key findings and implications of their report. Join us!